Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Santhera Pharmaceuticals Holdings Ltd (SPHDF)

Santhera Pharmaceuticals Holdings Ltd (SPHDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 49.60
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.2750 +8.76%
on 10/15/25
13.3500 unch
on 11/13/25
+0.0300 (+0.23%)
since 09/29/25
3-Month
12.2750 +8.76%
on 10/15/25
13.3500 unch
on 11/13/25
-5.0500 (-27.45%)
since 07/28/25

Most Recent Stories

More News
Santhera Pharmaceuticals Holding (SPHDF) Gets a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Santhera Pharmaceuticals Holding, with a price target of CHF30.00. The company’s shares closed last Monday at...

SPHDF : 13.3500 (+8.76%)
Analysts Offer Insights on Healthcare Companies: Santhera Pharmaceuticals Holding (OtherSPHDF) and Reviva Pharmaceuticals Holdings (RVPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Santhera Pharmaceuticals Holding (SPHDF – Research Report) and Reviva Pharmaceuticals Holdings (RVPH –...

RVPH : 0.6391 (-3.94%)
SPHDF : 13.3500 (+8.76%)

Key Turning Points

3rd Resistance Point 13.3500
2nd Resistance Point 13.3500
1st Resistance Point 13.3500
Last Price 13.3500
1st Support Level 13.3500
2nd Support Level 13.3500
3rd Support Level 13.3500

See More

52-Week High 19.0000
Fibonacci 61.8% 16.4310
Fibonacci 50% 15.6375
Fibonacci 38.2% 14.8439
Last Price 13.3500
52-Week Low 12.2750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar